Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire.
Pilar X AltmanGabriel OzorowskiRobyn L StanfieldJeremy HaakensonMichael AppelMara ParrenWen-Hsin LeeHuldah SangJordan WoehlKaren Saye-FranciscoCollin JoyceGe SongKatelyn PorterElise LandaisRaiees AndrabiIan A WilsonAndrew B WardWaithaka MwangiVaughn V SmiderDennis R BurtonDevin SokPublished in: bioRxiv : the preprint server for biology (2024)
The elicitation of epitope-specific broadly neutralizing antibodies is highly desirable for an HIV vaccine as bnAbs can prevent HIV infection in robust animal challenge models and humans, but to date, cows are the only model shown to reliably produce HIV bnAb responses on Envelope (Env) immunization. These responses involve Abs with ultralong CDRH3s and are all directed to a single site, the CD4 binding site. To determine whether this is a unique phenomenon or whether cow antibodies can target further bnAb sites on Env, we employed an immunization protocol that generated cow bnAbs to a second site, the V2-apex. We conclude that ultralong CDRH3s are well adapted to penetrate the glycan shield of HIV Env and recognize conserved regions and may constitute protein units, either in the context of antibodies or in other engineered proteins, that could be deployed as anti-HIV reagents.